Cardiovascular Risk in Patients With Primary Hyperparathyroidism

Study acronym: CVD-PHPT
StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
8,814 trials monitored
See 428 trials at risk
2,000 trials monitored
See 115 trials at risk
1,933 trials monitored
See 101 trials at risk
and 2 more diseases
Patients with primary hyperparathyroidism versus healthy controls assessed for their cardiovascular risk and overt CVD
Trial Details
NCT Number NCT07870369
Lead Sponsor Medical University of Sofia
Conditions
(from sponsor)
Heart Failure, Atrial Fibrillation (AF), Arrhythmia, Coronary Artery Disease, Hypertension (HTN)
Related terms Arrhythmias, Cardiac, Atrial Fibrillation, Coronary Artery Disease, Heart Failure, Hypertension
Enrollment 77 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov